BSG: Basigin
[Isoform 1]: Essential for normal retinal maturation and development.
- Drugs that act on it: 2
- Approved: 0
- In phases 1 to 3: 2
- Sponsors: 1
Who is on it, and how far along
Every drug ChEMBL records acting on BSG, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
- Antibody 2
| Gavilimomab | Phase 3 | Abgenix | Antibody | OtherBasigin other | 0 |
| Ziralimumab | Phase 2 | — | Antibody | InhibitorBasigin inhibitor | 0 |
- Inborn errors of metabolism0.37
- Neurodegenerative disease0.28
- Graft versus host disease0.23
- Neoplasm0.12
- Hepatocellular carcinoma0.12
- Cancer0.12
- Breast cancer0.12
- Rheumatoid arthritis0.12
- Breast carcinoma0.11
- Non-small cell lung carcinoma0.11
- Glioma0.11
- Central nervous system cancer0.11
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL3580492, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. Gene name, function (UniProt P35613, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets